Press Release
| August 23, 2011
Dewey & LeBoeuf Advising Omnicare on its Proposed US$716 Million Acquisition of PharMerica
The firm is advising Omnicare, Inc. (NYSE: OCR) on its proposed acquisition of PharMerica Corporation (NYSE: PMC) for US$15 per share of PharMerica common stock. The proposed transaction is valued at approximately US$716 million.
Dewey & LeBoeuf has previously advised Omnicare on a number of significant transactions, including Omnicare's $1.8 billion unsolicited acquisition of NeighborCare and $460 million unsolicited acquisition of NCS Healthcare.
The Dewey & LeBoeuf team is being led by Partner Mort Pierce, working with Partner Chang-Do Gong.
This memorandum is intended only as a general discussion of these issues. It is not considered to be legal advice. We would be pleased to provide additional details or advice about specific situations. For additional information on this important topic, please feel free to call upon your Dewey & LeBoeuf relationship partner. No part of this publication may be reproduced, in whole or in part, in any form, without our prior written consent.
For further information on Dewey & LeBoeuf, please visit www.dl.com. +1 888 532 6383